| 7501441 |
Naphthyl compounds, intermediates, processes, compositions, and methods |
George J. Cullinan, Jeffrey A. Dodge, Kennan J. Fahey, Charles D. Jones, Charles Willis Lugar, III +1 more |
2009-03-10 |
$203,125,000 |
| 6992097 |
Growth hormone secretagogues |
Kenneth Lee Hauser, Jeffrey A. Dodge, Mark L. Heiman, Scott Alan Jones, Charles A. Alt +16 more |
2006-01-31 |
$137,113,000 |
| 6812244 |
Naphthyl compounds, intermediates, compositions, and methods of use |
Thomas Alan Crowell, Charles D. Jones, Alan David Palkowitz |
2004-11-02 |
$322,095,000 |
| 6703407 |
Benzofuran compounds, compositions, and methods |
George J. Cullinan, Jeffrey A. Dodge, Kennan J. Fahey, Charles D. Jones |
2004-03-09 |
$149,189,000 |
| 6639076 |
Growth hormone secretagogues |
Kenneth Lee Hauser, Jeffrey A. Dodge, Mark L. Heiman, Scott Alan Jones, Charles A. Alt +11 more |
2003-10-28 |
$145,966,000 |
| 6599920 |
Naphthalene compounds, intermediates, formulations, and methods |
Thomas Alan Crowell, Charles D. Jones |
2003-07-29 |
$468,870,000 |
| 6593345 |
Naphthyl compounds, intermediates, compositions, and methods of use |
Thomas Alan Crowell, Charles D. Jones, Alan David Palkowitz |
2003-07-15 |
$528,876,000 |
| 6479517 |
Phosphorous-containing benzothiophenes |
Jeffrey A. Dodge, Jeffrey S. Nissen |
2002-11-12 |
$452,988,000 |
| 6437137 |
Naphthyl compounds, intermediates, processes, compositions, and methods |
George J. Cullinan, Jeffrey A. Dodge, Kennan J. Fahey, Charles D. Jones, Charles Willis Lugar, III +1 more |
2002-08-20 |
$92,904,000 |
| 6417198 |
Methods of inhibiting CNS problems in post-menopausal women |
Andrew L. Glasebrook, Timothy A. Grese, David L. Phillips |
2002-07-09 |
$83,855,000 |
| 6410564 |
Naphthyl compounds, intermediates, processes, compositions, and methods |
George J. Cullinan, Jeffrey A. Dodge, Kennan J. Fahey, Charles D. Jones, Charles Willis Lugar, III +1 more |
2002-06-25 |
$96,892,000 |
| 6407243 |
Benzofuran compounds, compositions, and methods |
George J. Cullinan, Jeffrey A. Dodge, Kennan J. Fahey, Charles D. Jones |
2002-06-18 |
$190,659,000 |
| 6399634 |
Benzothiophene compounds, compositions, and methods |
George J. Cullinan, Jeffrey A. Dodge, Kennan J. Fahey, Charles D. Jones |
2002-06-04 |
$122,963,000 |
| 6395755 |
Benzothiophene pharmaceutical compounds |
Jeffrey A. Dodge |
2002-05-28 |
$59,864,000 |
| 6395719 |
Methods for increasing levels of acetylcholine |
Michele Glinn, Steven M. Paul, Xin Wu |
2002-05-28 |
$59,864,000 |
| 6391892 |
Naphthyl pharmaceutical compounds |
Jeffrey A. Dodge |
2002-05-21 |
$135,593,000 |
| 6291484 |
Benzothiophenes |
Jeffrey A. Dodge |
2001-09-18 |
$377,210,000 |
| 6288108 |
Methods for increasing levels of acetylcholine |
Michele Glinn, Steven M. Paul, Xin Wu |
2001-09-11 |
|
| 6110942 |
Method for minimizing the uterotrophic effect of droloxifene |
Jeffrey A. Dodge |
2000-08-29 |
$353,600,000 |
| 6096764 |
Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration |
George J. Cullinan, Jeffrey A. Dodge |
2000-08-01 |
$336,613,000 |
| 6090843 |
Benzothiophenes compounds which have useful pharmaceutical activity |
Jeffrey A. Dodge |
2000-07-18 |
$169,901,000 |
| 6077852 |
Treatment of central nervous system disorders with selective estrogen receptor modulators |
Kelly R. Bales, Steven M. Paul, Mary Patricia Knadler |
2000-06-20 |
$939,768,000 |
| 6025381 |
Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
Jeffrey A. Dodge |
2000-02-15 |
$61,885,000 |
| 6020513 |
Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
Thomas Alan Crowell, Charles D. Jones |
2000-02-01 |
$115,050,000 |
| 6017914 |
Benzo[b]thiophene compounds, intermediates, formulations, and methods |
Michael J. Martin, Ken Matsumoto |
2000-01-25 |
$154,738,000 |
